XML 81 R18.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes
12 Months Ended
Dec. 31, 2019
Income Taxes  
Income Taxes

11. Income taxes

INCOME TAXES

The following table summarizes the income tax recognized in profit or loss for the years ended December 31, 2019, 2018 and 2017.

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31,

 

    

2019

    

2018

    

2017

 

 

(Euro, in thousands)

 

 

 

 

 

 

 

 

 

 

Current tax

 

(1,372)

 

(584)

 

(218)

Deferred tax

 

 

1,158

 

 

535

 

 

20

Income taxes

 

(214)

 

(50)

 

(198)

 

 

 

 

 

 

 

 

 

 

 

TAX LIABILITIES

The below table illustrates the tax liabilities related captions in the consolidated statement of financial positionas at December 31, 2019, 2018 and 2017.

 

 

 

 

 

 

 

 

 

 

 

 

December 31,

 

    

2019

    

2018

    

2017

 

 

(Euro, in thousands)

Current tax payable

 

2,037

 

1,175

 

865

Total tax liabilities

 

2,037

 

1,175

 

865

 

On December 31, 2018 and December 31, 2019, €1.2 million and €2.0 million of tax liabilities were primarily related to respectively five and four of our subsidiaries operating on a cost plus basis.

TAXES RECOGNIZED IN STATEMENT OF OPERATIONS

For the purpose of the disclosure below corporation tax was calculated at 29.58% (2018: 29.58%, 2017: 34%)—which is the tax rate applied in Belgium—on the estimated assessable profit for the year. The applied tax rate for other territorial jurisdictions was the tax rate that is applicable in these respective territorial jurisdictions on the estimated taxable result of the accounting year.

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31,

 

    

2019

    

2018

    

2017

 

 

(Euro, in thousands)

 

 

 

 

 

 

 

 

 

 

Income/loss (-) before tax

 

150,060

 

(29,209)

 

(115,507)

Income tax debit/credit (-), calculated using the Belgian statutory tax rate on the accounting income/loss (-) before tax (theoretical)

 

 

44,388

 

 

(8,640)

 

 

(39,261)

Tax expenses/income (-) in statement of operations (effective)

 

 

214

 

 

50

 

 

198

Difference in tax expense/income to explain

 

(44,173)

 

8,690

 

39,458

 

 

 

 

 

 

 

 

 

 

Effect of tax rates in other jurisdictions

 

831

 

411

 

14

Effect of non taxable revenues

 

 

(13,079)

 

 

(11,558)

 

 

(11,277)

Effect of share based payment expenses without tax impact

 

 

10,318

 

 

7,530

 

 

5,317

Effect of expenses/income (-) not subject to tax

 

 

53,270

 

 

382

 

 

102

Effect of non tax deductible expenses

 

 

795

 

 

945

 

 

404

Effect of recognition of previously non recognized deferred tax assets

 

 

(2,286)

 

 

(1,977)

 

 

(414)

Effect of change in tax rates

 

 

 —

 

 

 —

 

 

181

Effect of tax losses (utilized) reversed

 

 

(136)

 

 

(150)

 

 

(763)

Effect of under or over provision in prior periods

 

 

30

 

 

 —

 

 

 —

Effect of non recognition of deferred tax assets

 

 

47,413

 

 

13,108

 

 

45,895

Effect of derecognition of previously recognized deferred tax assets

 

 

106

 

 

 —

 

 

 —

Effect of use of IID

 

 

(141,435)

 

 

 —

 

 

 —

Total explanations

 

(44,173)

 

8,690

 

39,458

 

Non-taxable revenues for the years ended December 31, 2019, 2018 and 2017 related to non-taxable subsidies and tax credits. Expenses/income (-) not subject to tax for the year ended December 31, 2019 mainly consisted of the fair value re-measurement of the derivative financial liabilities related to the share subscription agreement and the warrants granted to Gilead (see note 9). The use of the IID for the year ended December 31, 2019 referred to the “innovation income deduction” regime in Belgium. This regime allows net profits attributable to revenue from among others patented products (or products for which the patent application is pending) to be taxed at a lower effective tax rate than other revenues. The effective tax rate can thus be reduced up to 4.4%  (3.75% as of January 1, 2020).